Stem cell studies point the way to broadly effective treatments for ALS

In the quest to find a cure for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, researchers led by Justin Ichida, PhD — head of the Ichida Lab at the Read More »

February 7th, 2023|Announcements, Keck Net Intranet|

Keck School program to study skin of color welcomes new fellow and new supporter

At the Keck School of Medicine of USC, the Skin of Color and Pigmentary Disorders Research Fellowship is part of a growing effort to end the disparities that patients of color face in dermatological care. This year’s Read More »

February 6th, 2023|Announcements, Keck Net Intranet|

Meet Shannon Bradley, Keck Medicine of USC’s new chief diversity and inclusion officer

Last year, Shannon Bradley, MBA, became the first chief diversity and inclusion officer at Keck Medicine of USC. Her role, which began Sept. 26, is focused on developing new strategies and initiatives to further the organization’s existing diversity, equity and Read More »

February 6th, 2023|featured, Keck Net Intranet|

Electric vehicles linked to reduced air pollution and improved health

In the first study to use real-world data to link electric cars, air pollution and health, researchers from the Keck School of Medicine of USC have begun to document the impact of electric vehicle (ZEV) adoption. Leveraging publicly available datasets, Read More »

February 3rd, 2023|Announcements, Keck Net Intranet|

USC Norris Blood and Marrow Transplant and Cell Therapy Program achieves 90.3% one-year survival rate

A new federal report shows that the USC Norris Blood and Marrow Transplant and Cell Therapy Program, an adult-only program at USC Norris Comprehensive Cancer Center, has achieved a historic one-year survival rate of 90.3%. This surpasses Read More »

February 1st, 2023|Announcements, Keck Net Intranet|